Furthermore, the inclusion of variables that can be subjective and difficult to assess (e.g., encephalopathy) or modifiable by supportive measures such as blood product administration (e.g., PT/INR, fibrinogen), extracorporeal support devices (e.g., ammonia, bilirubin, lactate), or replacement supplementation (e.g., phosphorus, albumin) continues to limit their clinical impact. Here, ALB is linked to Encephalopathy.